| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/25/2013 | CN103468645A Pseudorabies virus, pseudorabies vaccine and preparation method of pseudorabies vaccine |
| 12/25/2013 | CN103467602A Compositions and methods for regulating NK cell activity |
| 12/25/2013 | CN103467598A Completely humanized neutralizing antibody for anti-rabies viruses |
| 12/25/2013 | CN103467590A Biological couplet, purine compounds for preparing biological couplet, synthetic method for preparing biological couplet, pharmaceutical preparation prepared from biological couplet and application of biological couplet in immune adjustment |
| 12/25/2013 | CN103467589A Recombinant short-necked clam tumor necrosis factor RpTNF as well as construction and application thereof |
| 12/25/2013 | CN103467581A Influenza virus M1 protein, and encoding gene and application of influenza virus M1 protein |
| 12/25/2013 | CN103467571A Livestock and poultry immune enhancer bursa fabricius polypeptide |
| 12/25/2013 | CN103463645A Fish Vibrio. alginolyticus anti-idiotype antibody genetic engineering vaccine and preparation method thereof |
| 12/25/2013 | CN103463640A Canine distemper virus live vaccine heat-resisting cryoprotectant and preparation method thereof |
| 12/25/2013 | CN103463634A Immunopotentiator and application method thereof |
| 12/25/2013 | CN103463633A Targeting chimeric hepatitis B core antigen therapeutic vaccine and uses thereof |
| 12/25/2013 | CN103463632A Preparation method for D type clostridium perfringen toxoid vaccine of cattle and sheep enterotoxaemia |
| 12/25/2013 | CN103463631A B cell vaccine based on Hepal-6 hepatoma cell autophagosome-DRibbles and preparation method of B cell vaccine |
| 12/25/2013 | CN103463630A Concurrent chemotherapy and immunotherapy |
| 12/25/2013 | CN103463629A Preparation method and application of premature ovarian failure non-human mammal model |
| 12/25/2013 | CN102875685B Chimeric antigen receptor hFVIIL-CD8-OX40-CD3zeta and application thereof |
| 12/25/2013 | CN102851385B Primer group utilizing LAMP to detect vibrio alginolyticus and rapid diagnosis kit employing primer group |
| 12/25/2013 | CN102766640B Method for preparing influenza A virus full-length M2 protein |
| 12/25/2013 | CN102743749B Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor |
| 12/25/2013 | CN102727879B Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine |
| 12/25/2013 | CN102702352B Human anti-EV71 virus neutralization antibody EV71FabL4 and preparation method and application thereof |
| 12/25/2013 | CN102604898B VP60 protein recombinant baculovirus carrying type O foot and mouth disease virus B cell epitope |
| 12/25/2013 | CN102372766B O-type foot-and-mouth disease multi-epitope vaccine |
| 12/25/2013 | CN102277368B Duck enteritis virus infectious recombinant cloning system and construction method and application thereof |
| 12/25/2013 | CN102241768B Antibody against hemagglutinin of influenza A H1N1 virus |
| 12/25/2013 | CN102220357B Multivalent vaccines comprising recombinant viral vectors |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/25/2013 | CN101883580B Subunit vaccine for aquaculture |
| 12/25/2013 | CN101809144B Method for producing flu virus |
| 12/25/2013 | CN101652388B Monoclonal human tumor-specific antibody |
| 12/25/2013 | CN101558082B Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 12/25/2013 | CN101501070B Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 12/25/2013 | CN101448520B Avian influenza viruses, vaccines, compositions, formulations, and methods |
| 12/25/2013 | CN101084438B B7-H1 and methods of diagnosis, prognosis, and treatment of cancer |
| 12/24/2013 | US8614301 Methods of treating cancer using anti CD24 antibodies |
| 12/24/2013 | US8614299 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide |
| 12/24/2013 | US8614298 Humanized anti-amyloid beta antibodies |
| 12/24/2013 | US8614295 Antibody molecules having specificity for human OX40 |
| 12/24/2013 | US8614185 Fusion proteins of alpha-MSH derivatives and Fc |
| 12/24/2013 | US8614183 Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2 |
| 12/24/2013 | US8614177 Peptides |
| 12/24/2013 | US8614090 Astrovirus species |
| 12/24/2013 | US8614082 Attenuation of encephalitogenic alphavirus and uses thereof |
| 12/24/2013 | US8614064 Methods of diagnosing atherosclerosis by measuring ApoCI |
| 12/24/2013 | US8613936 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
| 12/24/2013 | US8613935 Influenza hemagglutinin and neuraminidase variants |
| 12/24/2013 | US8613934 Cellular and viral inactivation |
| 12/24/2013 | US8613933 Brachyury polypeptides and methods for use |
| 12/24/2013 | US8613932 GP100-specific T cell receptors and related materials and methods of use |
| 12/24/2013 | US8613931 Compounds for treating beta-amyloidoses |
| 12/24/2013 | US8613930 Cross-linkers and their uses |
| 12/24/2013 | US8613929 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
| 12/24/2013 | US8613928 Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein |
| 12/24/2013 | US8613927 High affinity human antibodies to human nerve growth factor |
| 12/24/2013 | US8613926 Anti-C5a receptor antibodies |
| 12/24/2013 | US8613925 Anti-IL-13Rα1 antibodies and their uses thereof |
| 12/24/2013 | US8613924 Antibodies that specifically bind to A beta oligomers and use thereof |
| 12/24/2013 | US8613923 Monoclonal antibody |
| 12/24/2013 | US8613922 Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP) |
| 12/24/2013 | US8613921 Antibodies that bind TGF-alpha and epiregulin |
| 12/24/2013 | US8613920 Treatment of amyloidogenic diseases |
| 12/24/2013 | US8613919 High concentration antibody and protein formulations |
| 12/24/2013 | US8613907 Compositions that inhibit proliferation of cancer cells |
| 12/24/2013 | US8613903 Humanized L243 antibodies |
| 12/24/2013 | DE102008033381B4 Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden Modulation of the immune response by the receptor NKp65 and its ligands |
| 12/24/2013 | CA2707684C Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 12/24/2013 | CA2698667C Human gm-csf antigen binding proteins |
| 12/24/2013 | CA2555393C Hybrid proteins of active-site serine beta-lactamase |
| 12/24/2013 | CA2545939C Immunoglobulin preparations having increased stability |
| 12/24/2013 | CA2513744C Depletion of endogenous primordial germ cells in avian species |
| 12/24/2013 | CA2493834C Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 12/24/2013 | CA2487915C Allergen from mugwort pollen |
| 12/24/2013 | CA2457461C Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2395945C Novel chimeric proteins and methods for using the same |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/19/2013 | WO2013188870A2 IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME |
| 12/19/2013 | WO2013188855A1 Anti-pcsk9 antibodies, formulations, dosing, and methods of use |
| 12/19/2013 | WO2013188786A1 Compositions and methods for treating airway inflammatory diseases |
| 12/19/2013 | WO2013188715A2 Compositions and methods for treating cancer |
| 12/19/2013 | WO2013188699A1 Compositions, methods and devices for activating an immune response |
| 12/19/2013 | WO2013188693A1 Antigen binding constructs to cd3 |
| 12/19/2013 | WO2013188673A2 Reassortant btv and ahsv vaccines |
| 12/19/2013 | WO2013188666A1 Beta-2 chimaerin as a mediator of axonal and synaptic pruning |
| 12/19/2013 | WO2013188627A2 Cationic lipid vaccine compositions and methods of use |
| 12/19/2013 | WO2013188534A1 Biomaterials for the prevention of post-operative adhesions |
| 12/19/2013 | WO2013188529A1 Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium |
| 12/19/2013 | WO2013188494A1 Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies |
| 12/19/2013 | WO2013188448A2 Dual receptor antagonistic antigen-binding proteins and uses thereof |
| 12/19/2013 | WO2013188315A1 Compositions and methods for administration of vaccines against dengue virus |
| 12/19/2013 | WO2013187954A1 Magnetic labeling of bacteria |
| 12/19/2013 | WO2013187730A1 Composition for preventing or treating fracture or osteoporosis using slit-robo system |
| 12/19/2013 | WO2013187724A1 Novel antibody specific for clec14a and uses thereof |
| 12/19/2013 | WO2013187556A1 Novel antibody specific for clec14a and uses thereof |
| 12/19/2013 | WO2013187495A1 ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED Fc REGION |
| 12/19/2013 | WO2013187371A1 Method for detecting cancer, and antibody capable of recognizing pancreas-specific ribonuclease 1 |
| 12/19/2013 | WO2013186793A1 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells |
| 12/19/2013 | WO2013186753A1 Vaccines for serogroup x meningococcus |
| 12/19/2013 | WO2013186752A1 Monoclonal antibodies able to bind the viral hcv e2 protein preparation and use thereof |
| 12/19/2013 | WO2013186719A1 Improved antagonist antibodies against gdf-8 and uses therefor |